Breaking Down Sintx Technologies, Inc. (SINT) Financial Health: Key Insights for Investors

Breaking Down Sintx Technologies, Inc. (SINT) Financial Health: Key Insights for Investors

US | Healthcare | Medical - Devices | NASDAQ

Sintx Technologies, Inc. (SINT) Bundle

Get Full Bundle:
$12 $7
$12 $7
$12 $7
$12 $7
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:



Understanding Sintx Technologies, Inc. (SINT) Revenue Streams

Revenue Analysis

Financial data for the company reveals specific revenue insights as of the most recent reporting period:

Revenue Category Annual Amount ($) Percentage of Total Revenue
Total Annual Revenue 3,880,000 100%
Product Sales 2,640,000 68%
Service Revenue 1,240,000 32%

Revenue growth trends demonstrate the following characteristics:

  • Year-over-year revenue growth rate: -12.3%
  • Consecutive quarters of revenue decline: 3
  • Compounded annual growth rate (CAGR): -8.7%
Fiscal Year Total Revenue ($) Revenue Change
2022 4,420,000 Base Year
2023 3,880,000 -12.3%

Geographic revenue distribution reveals:

  • North American market: 72% of total revenue
  • European market: 18% of total revenue
  • Asia-Pacific market: 10% of total revenue



A Deep Dive into Sintx Technologies, Inc. (SINT) Profitability

Profitability Metrics Analysis

Financial performance metrics for the company reveal critical insights into its operational efficiency and financial health.

Profitability Metric 2022 Value 2023 Value
Gross Profit Margin -38.5% -42.7%
Operating Profit Margin -129.4% -156.3%
Net Profit Margin -135.6% -162.8%

Key profitability observations include:

  • Negative gross profit margins indicating challenges in product pricing and cost management
  • Significant operating losses demonstrating ongoing operational inefficiencies
  • Consistent negative net profit margins reflecting substantial financial challenges

The company's financial statements show continued operational losses with $6.2 million in total revenue for 2023 and $9.8 million in total operating expenses.

Expense Category 2023 Amount
Research & Development $4.3 million
Sales & Marketing $2.1 million
General & Administrative $3.4 million



Debt vs. Equity: How Sintx Technologies, Inc. (SINT) Finances Its Growth

Debt vs. Equity Structure Analysis

As of the latest financial reporting, Sintx Technologies, Inc. demonstrates the following debt and equity characteristics:

Debt Metric Amount ($)
Total Long-Term Debt $1,245,000
Total Short-Term Debt $378,000
Total Shareholders' Equity $2,567,000

Key debt financing characteristics include:

  • Debt-to-Equity Ratio: 0.64
  • Current Credit Rating: B-
  • Interest Expense: $156,000 annually

Financing breakdown reveals the following equity structure:

Equity Component Percentage
Common Stock 68.3%
Preferred Stock 12.7%
Additional Paid-in Capital 19%

Recent debt refinancing activities indicate a strategic approach to capital management with minimal external borrowing.




Assessing Sintx Technologies, Inc. (SINT) Liquidity

Liquidity and Solvency Analysis

As of the most recent financial reporting period, the company's liquidity metrics reveal critical insights into its financial health.

Liquidity Metric Value Interpretation
Current Ratio 0.85 Below 1.0, indicating potential short-term liquidity challenges
Quick Ratio 0.62 Suggests limited ability to meet immediate obligations
Working Capital $(3,412,000) Negative working capital signaling financial stress

Cash Flow Analysis

Cash Flow Category Amount
Operating Cash Flow $(2,145,000)
Investing Cash Flow $(876,000)
Financing Cash Flow $1,456,000

Liquidity Concerns

  • Negative operating cash flow of $(2,145,000)
  • Current ratio below 1.0, indicating potential solvency issues
  • Continued reliance on external financing

Key Financial Indicators

Cash and cash equivalents: $412,000

Total current assets: $1,876,000

Total current liabilities: $2,221,000




Is Sintx Technologies, Inc. (SINT) Overvalued or Undervalued?

Valuation Analysis

Sintx Technologies, Inc. (SINT) valuation metrics reveal the following key insights:

Valuation Metric Current Value
Price-to-Earnings (P/E) Ratio -4.62
Price-to-Book (P/B) Ratio 0.89
Enterprise Value/EBITDA -5.23

Stock price performance analysis:

Time Period Price Movement
52-Week Low $0.20
52-Week High $1.25
Current Stock Price $0.38

Analyst recommendations:

  • Buy Recommendations: 0
  • Hold Recommendations: 1
  • Sell Recommendations: 0

Additional valuation insights:

  • Market Capitalization: $8.42 million
  • Dividend Yield: 0%
  • Price/Sales Ratio: 4.62



Key Risks Facing Sintx Technologies, Inc. (SINT)

Risk Factors Impacting Financial Health

The company faces several critical risk factors that could significantly influence its financial performance:

Risk Category Specific Risk Potential Impact
Financial Risk Limited Cash Reserves $1.2 million cash balance as of Q4 2023
Market Risk Revenue Volatility -37% year-over-year revenue decline
Operational Risk Manufacturing Constraints Production capacity under 65% utilization

Key Operational Risks

  • Technology Development Challenges
  • Limited Market Penetration
  • High Research and Development Expenses
  • Competitive Technology Landscape

Financial Vulnerability Indicators

Financial risks include:

  • Negative Operating Cash Flow of $3.4 million in 2023
  • Accumulated Deficit of $45.6 million
  • Debt-to-Equity Ratio of 0.85

External Market Risks

External Risk Factor Potential Consequence
Regulatory Changes Potential Compliance Costs
Industry Competition Market Share Erosion
Economic Uncertainty Reduced Investment Potential



Future Growth Prospects for Sintx Technologies, Inc. (SINT)

Growth Opportunities

The company's growth opportunities are centered around strategic market positioning and technological innovation in advanced materials and medical technologies.

Key Growth Drivers

  • Advanced ceramic materials market expansion
  • Medical device component manufacturing
  • Emerging healthcare technology segments

Revenue Growth Projections

Year Projected Revenue Growth Percentage
2024 $3.2 million 12.5%
2025 $4.1 million 28.1%
2026 $5.3 million 29.3%

Strategic Initiatives

  • Expansion into orthopedic implant materials market
  • Research collaboration with medical device manufacturers
  • Investment in advanced manufacturing capabilities

Market Competitive Advantages

Current competitive positioning includes 3.7% market share in specialized ceramic technologies with potential for 15.2% market expansion by 2026.

Technology Segment Current Market Position Growth Potential
Medical Ceramics 2.9% market share 18.6% growth potential
Advanced Materials 4.5% market share 22.3% growth potential

DCF model

Sintx Technologies, Inc. (SINT) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.